These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15804040)

  • 1. [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
    Dahl E; Lindstrand G
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):665. PubMed ID: 15804040
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug control within the EEC II: good possibilities for Sweden].
    Strandberg K
    Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147
    [No Abstract]   [Full Text] [Related]  

  • 3. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

  • 4. An underrecognized challenge in evaluating postmarketing drug safety.
    Roden DM
    Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug information services at Eli Lilly and Company.
    Pfeil-Doyle JL; Jones MD; Oberlin JA; Benitez J
    Am J Hosp Pharm; 1990 Sep; 47(9):1996-8. PubMed ID: 2220850
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the resources and organization of an industry-based drug information service.
    Colvin CL
    Am J Hosp Pharm; 1990 Sep; 47(9):1989-90. PubMed ID: 2220847
    [No Abstract]   [Full Text] [Related]  

  • 8. Some aspects of drug monitoring.
    Venulet J
    Adverse Drug React Acute Poisoning Rev; 1985; 4(3):161-75. PubMed ID: 4061160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some aspects on drug safety control].
    Pekkarienen A
    Nord Med; 1967 Nov; 78(47):1539-42. PubMed ID: 6075273
    [No Abstract]   [Full Text] [Related]  

  • 10. Sales reps: footsoldiers in drug company wars.
    Prescrire Int; 2004 Jun; 13(71):116. PubMed ID: 15233155
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 12. [A deep-drawn sigh from a clinician].
    Hill S
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1703-4. PubMed ID: 15976848
    [No Abstract]   [Full Text] [Related]  

  • 13. Your health in the 21st century. A better safety net.
    Rosenberg D
    Newsweek; 2005; 145(26A):70-2. PubMed ID: 16375152
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quick drug investigations; desirable, useful and steady work].
    Olofsson C
    Vardfacket; 1978 Aug; 2(15):42-5. PubMed ID: 250385
    [No Abstract]   [Full Text] [Related]  

  • 15. [The activities of the Swiss drug monitoring center].
    Gartmann J
    Ther Umsch; 1982 Nov; 39(11):928-33. PubMed ID: 7179177
    [No Abstract]   [Full Text] [Related]  

  • 16. Pfizer's home remedy.
    Abkowitz A
    Fortune; 2009 Aug; 160(4):82-4, 86. PubMed ID: 19728588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse effects of drugs and computerized registries--a threat or a possibility?].
    Bergman U; Linnarsson R; Boethius G; Matell G; Keisu M; Peterson H; Kalles I; Wiholm BE; Krakau I; Westerholm B
    Lakartidningen; 1989 Apr; 86(16):1506-8. PubMed ID: 2725139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development and testing of a pilot information system for pharmacotherapy on the basis of linked data banks of pharmaceutical products and biomedical literature].
    Rosenkranz KO; Unger GE
    Methods Inf Med Suppl; 1978; 11():425-39. PubMed ID: 279773
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systematic follow up of inquiries about adverse drug reactions: a 9 month experience].
    Begaud B; Haramburu F; Père JC; Lorson B; Albin H; Dangoumau J
    Therapie; 1982; 37(4):433-5. PubMed ID: 7135326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Registration of adverse effects and complications].
    Asdahl T
    Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2114-5. PubMed ID: 5479234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.